Abstract
Background: In this study, we investigated transcranial magnetic stimulation (TMS)-derived markers of excitability and inhibition in methamphetamine (METH) use disorder. Methods: Sixteen methamphetamine users and 20 matched controls underwent psychological assessments, revised form of Symptom Checklist-90-Revised, cognitive assessment, anxiety and depression scales and TMS measures, including resting and active motor thresholds (RMT and AMT), motor evoked potential amplitude (MEP-A), cortical silent period (CSP), and short-interval intracortical inhibition (SICI). Results: METH users reported higher anxiety, depression, and somatization ( p < 0.001), while cognition remained preserved. They exhibited reduced RMT and AMT ( p < 0.001), indicating increased excitability, with no significant differences in MEP-A ( p = 0.083). CSP onset latency was prolonged at 150% RMT ( p = 0.042), suggesting impaired inhibition. Excitability thresholds correlated negatively with methamphetamine dose, while addiction duration was linked to CSP changes and obsessive-compulsive symptoms. Lower thresholds also correlated with greater interpersonal sensitivity and addiction severity. Conclusion: Increased cortical excitability and decreased inhibitory control are linked to METH usage, and these factors may be underlying psychiatric symptoms. TMS-derived indices show potential as biomarkers for neurophysiological monitoring and targeted interventions in methamphetamine use disorder.
Funding Information
  • Assiut University

This publication has 53 references indexed in Scilit: